A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation

J Virol. 2002 Jan;76(2):569-81. doi: 10.1128/jvi.76.2.569-581.2002.

Abstract

CD8(+) T lymphocytes can suppress human immunodeficiency virus type 1 (HIV-1) replication by secreting a soluble factor(s) known as CD8(+) T-lymphocyte antiviral factor (CAF). One site of CAF action is inhibition of HIV-1 RNA transcription, particularly at the step of long terminal repeat (LTR)-driven gene expression. However, the mechanism by which CAF inhibits LTR activation is not understood. Here, we show that conditioned media from several herpesvirus saimari-transformed CD8(+) T lymphocytes inhibit, in a time- and dose-dependent manner, the replication of HIV-1 pseudotype viruses that express the envelope glycoproteins of vesicular stomatitis virus (HIV-1(VSV)). The same conditioned media also inhibit phorbol myristate acetate-induced activation of the HIV-1 LTR and activate the signal transducer and activator of transcription 1 (STAT1) protein. We have obtained direct evidence that STAT1 is necessary for CAF-mediated inhibition of LTR activation and HIV-1 replication. Thus, the inhibitory effect of CAF on HIV-1(VSV) replication was abolished in STAT1-deficient cells. Moreover, CAF inhibition of LTR activation was diminished both in STAT1-deficient cells and in cells expressing a STAT1 dominant negative mutant but was restored when STAT1 was reintroduced into the STAT1-deficient cells. We also observed that CAF induced the expression of interferon regulatory factor 1 (IRF-1), and that IRF-1 gene induction was STAT-1 dependent. Taken together, our results suggest that CAF activates STAT1, leading to IRF-1 induction and inhibition of gene expression regulated by the HIV-1 LTR. This study therefore helps clarify one molecular mechanism of host defense against HIV-1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Biological Factors / chemistry
  • Biological Factors / metabolism*
  • Biological Factors / pharmacology
  • Biological Factors / physiology*
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism*
  • Cell Line, Transformed
  • Culture Media, Conditioned / chemistry
  • Culture Media, Conditioned / pharmacology
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / deficiency
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Dose-Response Relationship, Drug
  • Electrophoretic Mobility Shift Assay
  • Gene Expression Regulation, Viral / drug effects
  • Genes, Dominant / genetics
  • HIV Long Terminal Repeat / genetics
  • HIV-1 / drug effects
  • HIV-1 / physiology*
  • HeLa Cells
  • Herpesvirus 2, Saimiriine / physiology
  • Humans
  • Interferon Regulatory Factor-1
  • Interferon-gamma / analysis
  • Mutation / genetics
  • Phosphoproteins / biosynthesis
  • Phosphoproteins / metabolism
  • Protein Binding
  • STAT1 Transcription Factor
  • Solubility
  • Tetradecanoylphorbol Acetate / pharmacology
  • Time Factors
  • Trans-Activators / deficiency
  • Trans-Activators / genetics
  • Trans-Activators / metabolism*
  • Transcriptional Activation / drug effects
  • Transfection
  • Virus Replication* / drug effects

Substances

  • Biological Factors
  • Culture Media, Conditioned
  • DNA-Binding Proteins
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • Phosphoproteins
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Trans-Activators
  • Interferon-gamma
  • Tetradecanoylphorbol Acetate